SOLLINI, Martina
 Distribuzione geografica
Continente #
NA - Nord America 4.026
AS - Asia 2.857
EU - Europa 1.043
SA - Sud America 519
Continente sconosciuto - Info sul continente non disponibili 144
AF - Africa 123
OC - Oceania 8
Totale 8.720
Nazione #
US - Stati Uniti d'America 3.911
SG - Singapore 1.674
CN - Cina 540
BR - Brasile 420
VN - Vietnam 289
IT - Italia 261
FI - Finlandia 175
IE - Irlanda 136
DE - Germania 107
IN - India 77
GB - Regno Unito 72
SE - Svezia 67
CA - Canada 65
HK - Hong Kong 64
NG - Nigeria 63
FR - Francia 54
AR - Argentina 46
NL - Olanda 38
BD - Bangladesh 31
IQ - Iraq 27
MX - Messico 27
RU - Federazione Russa 25
ES - Italia 19
PL - Polonia 17
TR - Turchia 16
ZA - Sudafrica 14
BE - Belgio 13
CL - Cile 13
JP - Giappone 12
CO - Colombia 11
ID - Indonesia 11
IR - Iran 11
AT - Austria 10
EC - Ecuador 10
IL - Israele 10
PK - Pakistan 10
UZ - Uzbekistan 10
TN - Tunisia 9
UA - Ucraina 9
EU - Europa 8
LT - Lituania 8
PH - Filippine 8
SA - Arabia Saudita 8
VE - Venezuela 8
KG - Kirghizistan 7
MY - Malesia 7
AU - Australia 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
JM - Giamaica 6
MA - Marocco 6
JO - Giordania 5
KE - Kenya 5
KZ - Kazakistan 5
PE - Perù 5
AZ - Azerbaigian 4
CH - Svizzera 4
HR - Croazia 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
SN - Senegal 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
LB - Libano 3
NI - Nicaragua 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
SY - Repubblica araba siriana 3
EE - Estonia 2
KR - Corea 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
PS - Palestinian Territory 1
Totale 8.580
Città #
Singapore 738
Ashburn 542
San Jose 330
Chandler 280
The Dalles 240
Wilmington 226
Shanghai 216
Helsinki 175
Dallas 172
Beijing 169
New York 149
San Mateo 147
Council Bluffs 137
Dublin 135
Boardman 122
Ho Chi Minh City 110
Milan 105
Ann Arbor 91
Los Angeles 75
Santa Clara 72
Benin City 63
Lawrence 60
Princeton 60
Hong Kong 57
Hanoi 56
Pune 42
Leawood 41
London 39
Amsterdam 34
São Paulo 34
Rome 33
Buffalo 30
Toronto 30
Phoenix 29
Paris 28
Fairfield 26
Seattle 26
Da Nang 25
Brooklyn 23
Woodbridge 23
Monmouth Junction 21
Haiphong 19
Rio de Janeiro 16
Warsaw 16
Belo Horizonte 15
Montreal 15
Orem 14
Boston 13
Brussels 13
Florence 13
Redwood City 13
Baghdad 12
Naples 12
Falkenstein 11
Johannesburg 11
Stockholm 11
Manchester 10
Moscow 10
Munich 10
Tashkent 10
Atlanta 9
Brasília 9
Curitiba 9
Figino 9
Mexico City 9
Miami 9
Norwalk 9
Porto Alegre 9
San Francisco 9
Campinas 8
Chicago 8
Santiago 8
Tokyo 8
Charlotte 7
Chennai 7
Cincinnati 7
Des Moines 7
Kocaeli 7
Pittsburgh 7
Zhengzhou 7
Bishkek 6
Redmond 6
Reston 6
San Diego 6
Sorocaba 6
Turin 6
Vienna 6
Addis Ababa 5
Biên Hòa 5
Calgary 5
Denver 5
Düsseldorf 5
Fortaleza 5
Goiânia 5
Hangzhou 5
Houston 5
Ipatinga 5
Kuala Lumpur 5
Munro 5
Nairobi 5
Totale 5.524
Nome #
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 134
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 130
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 126
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 124
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 119
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 107
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 106
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 106
[18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results 102
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 99
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 99
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 96
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 96
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 95
PET/CT radiomics in breast cancer: Mind the step 94
Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists 94
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019 93
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 92
Cardiac molecular pathways influenced by doxorubicin treatment in mice 92
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 91
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 91
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology 91
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 91
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 89
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 89
Radiomics of Liver Metastases: A Systematic Review 89
Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer 86
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 86
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 85
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 84
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 83
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 82
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 82
The "3M" Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary 82
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment 82
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 81
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 80
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication 80
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 79
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 78
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 78
Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018 78
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 78
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 78
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 77
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 76
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 75
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 75
Methodological framework for radiomics applications in Hodgkin’s lymphoma 75
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI 73
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 72
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 71
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 70
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience 70
PET/MRI in Infection and Inflammation 69
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 69
18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study 69
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 67
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 67
Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy. 66
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome 65
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 64
Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer 64
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 62
The Development of an Intelligent Agent to Detect and Non-Invasively Characterize Lung Lesions on CT Scans: Ready for the "Real World"? 61
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 60
Alternative Nuclear Imaging Tools for Infection Imaging 60
The use of 18F-FDG-PET/CT in the diagnostic workup of CIED infections: another perspective 59
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 59
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 59
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 59
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 58
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results 57
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021 56
[18F]FDG-PET/CT texture analysis in thyroid incidentaloma: preliminary results 56
PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors 56
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 55
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 55
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 55
Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction 54
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 54
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 54
Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact 54
Total glycolytic volume and biological markers in mesothelioma patients 53
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 52
(18)F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer 52
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 52
Radiomics of Biliary Tumors: A Systematic Review of Current Evidence 51
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 51
Current Status of Molecular Imaging in Infections 50
The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas 49
Methodological Aspects of Lymphoscintigraphy: Bicompartmental Versus Monocompartmental Radiocolloid Administration 49
Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance 48
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis 47
Nuclear Medicine Imaging of Spondylodiscitis: The Emerging Role of PET 47
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 46
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 45
The role of imaging in the diagnosis of recurrence of primary seminal vesicle adenocarcinoma 45
Biomarkers in well differentiated thyroid cancer 45
Reply to: "Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings" 45
Totale 7.401
Categoria #
all - tutte 57.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022366 0 0 25 85 16 7 8 45 35 23 101 21
2022/20231.030 136 54 79 71 84 45 10 108 186 107 127 23
2023/20241.076 71 109 211 81 38 169 80 44 29 19 94 131
2024/20251.378 37 7 12 16 16 165 78 91 248 319 176 213
2025/20263.756 574 224 182 350 145 198 1.046 199 233 218 167 220
2026/2027548 296 251 1 0 0 0 0 0 0 0 0 0
Totale 8.720